Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)

BNRE20190002BUndetermined Publication Date: 2019-02-28AMGEN INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: BNRE20190002
Authority / Receiving Office: BN · BN
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2008-08-04
Filing Date: 2008-08-22
Publication Date: 2019-02-28
Estimated Expiration: 2028-08-22

Application Information

Patent Timeline

04 Aug 2008

Priority

22 Aug 2008

Application

BNRE20190002

28 Feb 2019

Publication

BNRE20190002B

IPC: A61K; A61P; C07K

Inventors: KING, CHADWICK, TERENCE; KETCHEM, RANDAL, ROBERT

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.

Need to check novelty before this filing date? Find Prior Art